BioSpace News Archive

Neurotrope has also been selected to present at the 25th Annual NewsMakers in the Biotech Industry on September 7th, 2018

HACKENSACK, N.J., /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the first quarter ended July 31, 2018, on Thursday, September 13, 2018, after market close.

Myovant Sciences (NYSE: MYOV), a leading clinical-stage biopharmaceutical company focused on women’s health and endocrine diseases, today announced its participation in the following upcoming investor conferences:

Community Senior Services (CSS), a nonprofit community service organization, announces that it has now provided more than 250,000 trips and two million miles of volunteer transportation for senior and disabled residents who live in sixteen Southern California

A live webcast of the presentation for each of these conferences, excluding the BioCentury NewsMakers lunch panel discussion, will be available on the Investors/Media section of Infinity’s website

Tenax Therapeutics , Inc. (NASDAQ: TENX) today announced the results of a new study titled “Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment: A Randomized Double‐Blind Controlled Trial” were published in the August 21, 2018 issue of the Journal of the American Heart Association (

Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it has entered into amendments with The University of Texas MD Anderson Cancer Center (MD Anderson) to extend the terms of two option agreements between Genprex and MD Anderson

Posters Include Interim Data from Wearable Health Technology Study and Research Initiatives to Evaluate Prescription Drug Monitoring, Take Back Programs, and Factors Influencing Opioid Use Disorder Diagnosis

(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.

Expect more from cannabidiol (CBD) with Infinite CBD’s new line of NANO CBD, available now. Utilizing the same nanotechnology that changed the way chemists made medicine for drug delivery, Infinite CBD is changing the way the world consumes CBD nutrients.